Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer
Conditions: Breast Cancer; Invasive Ductal Breast Carcinoma; Invasive Lobular Breast Carcinoma Intervention: Diagnostic Test: Radiomic, pathomic, and clinical markers Sponsor: Sunnybrook Health Sciences Centre Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Research